[go: up one dir, main page]

ECSP077416A - Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos - Google Patents

Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos

Info

Publication number
ECSP077416A
ECSP077416A EC2007007416A ECSP077416A ECSP077416A EC SP077416 A ECSP077416 A EC SP077416A EC 2007007416 A EC2007007416 A EC 2007007416A EC SP077416 A ECSP077416 A EC SP077416A EC SP077416 A ECSP077416 A EC SP077416A
Authority
EC
Ecuador
Prior art keywords
methods
mimeticbodies
join
compositions
melanocortine
Prior art date
Application number
EC2007007416A
Other languages
English (en)
Inventor
Chichi Huang
Mark Cunningham
Vedrana Stojanovic-Susulic
Karyn O'neil
Jeffrey Luo
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of ECSP077416A publication Critical patent/ECSP077416A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68Melanocyte-stimulating hormone [MSH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796Receptors; Cell surface antigens; Cell surface determinants for hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se expone un polipéptido de mimeticuerpo de unión al receptor de melanocortina; se exponen también polinucleótidos que codifican estos polipéptidos, células que comprenden estos polinucleótidos o que expresan los mimeticuerpos, y métodos de hacer y usar los anteriores.
EC2007007416A 2004-10-25 2007-04-25 Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos ECSP077416A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25

Publications (1)

Publication Number Publication Date
ECSP077416A true ECSP077416A (es) 2007-05-30

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007416A ECSP077416A (es) 2004-10-25 2007-04-25 Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos

Country Status (29)

Country Link
US (1) US20060105951A1 (es)
EP (1) EP1812046B1 (es)
JP (1) JP2008517605A (es)
KR (1) KR101255140B1 (es)
CN (1) CN101437540B (es)
AT (1) ATE501731T1 (es)
AU (1) AU2005299440B2 (es)
BR (1) BRPI0518411A2 (es)
CA (1) CA2585287A1 (es)
CY (1) CY1111486T1 (es)
DE (1) DE602005026970D1 (es)
DK (1) DK1812046T3 (es)
EA (1) EA200700944A1 (es)
EC (1) ECSP077416A (es)
ES (1) ES2363023T3 (es)
HK (1) HK1106445A1 (es)
HR (1) HRP20110405T1 (es)
IL (1) IL182683A0 (es)
MA (1) MA28943B1 (es)
ME (1) ME01234B (es)
MX (1) MX2007004974A (es)
NO (1) NO20072499L (es)
PL (1) PL1812046T3 (es)
PT (1) PT1812046E (es)
RS (1) RS51789B (es)
SI (1) SI1812046T1 (es)
TN (1) TNSN07157A1 (es)
WO (1) WO2006047535A2 (es)
ZA (1) ZA200704260B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910101B2 (en) * 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
CA2727317C (en) 2008-06-09 2015-02-17 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US20090305960A1 (en) * 2008-06-09 2009-12-10 Palatin Technologies, Inc Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
EA020959B1 (ru) 2009-06-08 2015-03-31 Палатин Текнолоджиз, Инк. Пептиды, специфичные к меланокортиновым рецепторам
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
MX2012005862A (es) 2009-11-23 2012-09-07 Palatin Technologies Inc Peptidos ciclicos especificos del receptor de melanocortina-1.
BR112012011780A2 (pt) 2009-11-23 2019-09-24 Palatin Technologies, Inc peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー/エス 抗体重鎖のc末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) * 2019-03-02 2020-09-10 上海一宸医药科技有限公司 一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1137340A4 (en) 1998-12-09 2005-12-21 Eleanor Roosevelt Inst COMPOSITION AND METHODS FOR REGULATION OF BODY WEIGHT AND ASSOCIATED PATHOLOGIES
EP1303625A2 (en) * 2000-07-14 2003-04-23 Zycos Inc. Alpha-msh related compounds and methods of use
CA2490409A1 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses
BR0312276A (pt) * 2002-06-28 2005-04-26 Centocor Inc Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos
WO2005097175A2 (en) * 2004-03-31 2005-10-20 Centocor, Inc. Human glp-1 mimetibodies, compositions, methods and uses

Also Published As

Publication number Publication date
US20060105951A1 (en) 2006-05-18
ME01234B (me) 2013-06-20
HRP20110405T1 (hr) 2011-06-30
WO2006047535A2 (en) 2006-05-04
PL1812046T3 (pl) 2011-08-31
ZA200704260B (en) 2009-03-25
RS51789B (en) 2011-12-31
KR101255140B1 (ko) 2013-04-22
DK1812046T3 (da) 2011-06-06
EP1812046A4 (en) 2009-11-11
SI1812046T1 (sl) 2011-06-30
AU2005299440A1 (en) 2006-05-04
JP2008517605A (ja) 2008-05-29
MA28943B1 (fr) 2007-10-01
NO20072499L (no) 2007-07-16
ATE501731T1 (de) 2011-04-15
EP1812046A2 (en) 2007-08-01
EP1812046B1 (en) 2011-03-16
TNSN07157A1 (en) 2008-11-21
IL182683A0 (en) 2007-09-20
ES2363023T3 (es) 2011-07-19
BRPI0518411A2 (pt) 2008-11-18
PT1812046E (pt) 2011-06-28
EA200700944A1 (ru) 2008-04-28
CY1111486T1 (el) 2015-08-05
DE602005026970D1 (de) 2011-04-28
CN101437540A (zh) 2009-05-20
KR20070085416A (ko) 2007-08-27
CN101437540B (zh) 2012-12-19
MX2007004974A (es) 2007-10-17
CA2585287A1 (en) 2006-05-04
AU2005299440B2 (en) 2011-12-15
WO2006047535A3 (en) 2008-09-04
HK1106445A1 (en) 2008-03-14

Similar Documents

Publication Publication Date Title
ECSP077416A (es) Mimeticuerpos que se unen al receptor de melanocortina, composiciones, metodos y usos
BRPI0512235A (pt) polipeptìdeos ligadores de antìgenos e seus usos
MX2007013759A (es) Agentes de union de esclerostina.
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
NO345048B1 (no) Antigen-bindende protein som binder til humant IGF-1R, polynukleotid som koder for dette, samt plasmid og celle, og farmasøytisk sammensetning.
WO2006083276A3 (en) Interferon-alpha polypeptides and conjugates
MX348735B (es) Celulas madre mesenquimales que expresan los receptores tnf-alfa.
TW200611910A (en) Interferon-alpha polypeptides and conjugates
WO2006055689A3 (en) Protein scaffolds and uses thereof
WO2009007852A3 (en) Multipotent/pluripotent cells and methods
EP1991560A4 (en) PEPTIDE WITH CELL MEMBRANE PENETRATING EFFECT
DK1951273T3 (da) Anvendelse af lactobacillus til behandling af autoimmune sygdomme
DK3219328T3 (da) Humane anti-il-23-antistoffer, sammensætninger, fremgangsmåder og anvendelser
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
MX2008000230A (es) Proteinas de enlace il-6.
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
TW200739068A (en) Composite chromatography column
WO2008086035A3 (en) Split mutant hydrolase fusion reporter and uses thereof
WO2007059190A3 (en) Compositions of and methods of using stabilized psma dimers
ATE471169T1 (de) Engineering mit homing-faktoren
MX2007011411A (es) Interaccion rage/diaphanous y composiciones relacionadas y metodos.
WO2007127830A3 (en) Dep2 and its uses in major depressive disorder and other related disorders
UA107788C2 (en) A fusion protein of m. tuberculosis
ITMO20040313A1 (it) Mostarda di carpi detta fina.